Cargando…

Additive Effects of Cyclic Peptide [R4W4] When Added Alongside Azithromycin and Rifampicin against Mycobacterium avium Infection

Mycobacterium avium (M. avium), a type of nontuberculous mycobacteria (NTM), poses a risk for pulmonary infections and disseminated infections in immunocompromised individuals. Conventional treatment consists of a 12-month regimen of the first-line antibiotics rifampicin and azithromycin. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kelley, Melissa, Sasaninia, Kayvan, Abnousian, Arbi, Badaoui, Ali, Owens, James, Beever, Abrianna, Kachour, Nala, Tiwari, Rakesh Kumar, Venketaraman, Vishwanath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459066/ https://www.ncbi.nlm.nih.gov/pubmed/37624017 http://dx.doi.org/10.3390/pathogens12081057

Ejemplares similares

L-GSH Supplementation in Conjunction With Rifampicin Augments the Treatment Response to Mycobacterium tuberculosis in a Diabetic Mouse Model
por: Beever, Abrianna, et al.
Publicado: (2022)

Glutathione Modulates Efficacious Changes in the Immune Response against Tuberculosis
por: Abnousian, Arbi, et al.
Publicado: (2023)

Effects of Glutathione Diminishment on the Immune Responses against Mycobacterium tuberculosis Infection
por: Cao, Ruoqiong, et al.
Publicado: (2021)

Topical Absorption of Glutathione–Cyclodextrin Nanoparticle Complex in Healthy Human Subjects Improves Immune Response against Mycobacterium avium Infection
por: Sasaninia, Kayvan, et al.
Publicado: (2023)

Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems
por: Zhong, Weixia, et al.
Publicado: (2021)

Liposomal Glutathione Helps to Mitigate Mycobacterium tuberculosis Infection in the Lungs
por: Kachour, Nala, et al.
Publicado: (2022)

Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of Mycobacterium tuberculosis infection
por: Cao, Ruoqiong, et al.
Publicado: (2021)

General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus
por: To, Kimberly, et al.
Publicado: (2020)

The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering The Immune Responses Against Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes
por: To, Kimberly, et al.
Publicado: (2021)

Recent Developments in the Understanding of Immunity, Pathogenesis and Management of COVID-19
por: Yegiazaryan, Aram, et al.
Publicado: (2022)

Understanding the Relationship between Glutathione, TGF-β, and Vitamin D in Combating Mycobacterium tuberculosis Infections
por: Singh, Mohkam, et al.
Publicado: (2020)

Pathogenicity of Type I Interferons in Mycobacterium tuberculosis
por: Mundra, Akaash, et al.
Publicado: (2023)

Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes
por: To, Kimberly, et al.
Publicado: (2021)

The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease
por: Schildkraut, Jodie A., et al.
Publicado: (2023)

Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
por: Kim, Hyung-Jun, et al.
Publicado: (2019)

Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics
por: Baker, Kristin R., et al.
Publicado: (2019)

Cyclic Peptide [R(4)W(4)] in Improving the Ability of First-Line Antibiotics to Inhibit Mycobacterium tuberculosis Inside in vitro Human Granulomas
por: Hernandez, Joshua, et al.
Publicado: (2020)

In vitro performances of novel co-spray-dried azithromycin/rifampicin microparticles for Rhodococcus equi disease treatment
por: Rampacci, Elisa, et al.
Publicado: (2018)

Phenotypic Characterization of Rhodococcus equi Biofilm Grown In Vitro and Inhibiting and Dissolving Activity of Azithromycin/Rifampicin Treatment
por: Rampacci, Elisa, et al.
Publicado: (2019)

Editorial: Causes for Increased Susceptibility to Mycobacterium tuberculosis – A Close View of the Immune System
por: Venketaraman, Vishwanath
Publicado: (2015)

Recent Advances in Mycobacterial Research
por: Venketaraman, Vishwanath
Publicado: (2020)

Therapeutic implications of nano-encapsulated rifabutin, azithromycin & ethambutol against experimental Mycobacterium avium infection in mice
por: Grewal, Tapinder Kaur, et al.
Publicado: (2018)

Azithromycin: A promising treatment option for Mycobacterium avium complex pulmonary disease in case of intolerance to clarithromycin
por: Oshima, Kengo, et al.
Publicado: (2021)

Gefitinib Inhibits Rifampicin-Induced CYP3A4 Gene Expression in Human Hepatocytes
por: Abbott, Kodye L., et al.
Publicado: (2022)

Combined administration of rifampicin, ethambutol, and clarithromycin for the treatment of tenosynovitis of the hand caused by Mycobacterium avium complex: Case series and literature review
por: Kaji, Yoshio, et al.
Publicado: (2021)

Azithromycin/hydroxychloroquine: Various toxicities: 4 case reports
Publicado: (2021)

SARS-CoV-2 and the Immune Response in Pregnancy with Delta Variant Considerations
por: Rangchaikul, Patrida, et al.
Publicado: (2021)

Successful treatment with azithromycin and rifampicin of penicillin and cephalosporin insensitive pneumococcal osteomyelitis in a child with HIV infection: a case report
por: Riordan, Andrew I, et al.
Publicado: (2008)

Restoring Cytokine Balance in HIV-Positive Individuals with Low CD4 T Cell Counts
por: Valdivia, Anddre, et al.
Publicado: (2017)

Sensitivity and specificity of the mean corpuscular volume and CD4/CD8 ratio in discriminating between rifampicin resistant and rifampicin sensitive tuberculosis
por: Baruch Baluku, Joseph, et al.
Publicado: (2020)

Rejoinder: multiculturalism and interculturalism: alongside but separate
por: Zapata-Barrero, Ricard
Publicado: (2018)

Paradoxical facilitation alongside interhemispheric inhibition
por: Belyk, Michel, et al.
Publicado: (2021)

Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Electrocardiogram Variability
por: EL Ouarradi, Amal, et al.
Publicado: (2020)

Serum concentrations of clarithromycin and rifampicin in pulmonary Mycobacterium avium complex disease: long-term changes due to drug interactions and their association with clinical outcomes
por: Shimomura, Hitoshi, et al.
Publicado: (2015)

In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases
por: Wareham, David W, et al.
Publicado: (2006)

Mycobacterium tuberculosis
por: Venketaraman, Vishwanath, et al.
Publicado: (2015)

Effector Mechanisms of Neutrophils within the Innate Immune System in Response to Mycobacterium tuberculosis Infection
por: Warren, Eric, et al.
Publicado: (2017)

A Role of Intracellular Toll-Like Receptors (3, 7, and 9) in Response to Mycobacterium tuberculosis and Co-Infection with HIV
por: Nguyen, Huy, et al.
Publicado: (2020)

Editorial: Immunometabolic mechanisms underlying the severity of COVID-19
por: Kzhyshkowska, Julia, et al.
Publicado: (2022)

Editorial: Community series in immunometabolic mechanisms underlying the severity of COVID-19, volume II
por: Kzhyshkowska, Julia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sr0nunuoldjssoj6v50r3nj20u